Skip to content

Telehealth clinic compliance

The three-column licensure gap most clinics find too late

Clinical practice in the United States is licensed state by state, so a telehealth clinic has three separate coverage maps to reconcile, and the gap a LegitScript reviewer finds is almost always between where the marketing runs and where a prescriber or a pharmacy is actually permitted to operate.

By VeriScripts · · 5 min read

Ask a telehealth operator which states they serve and you get a number. Ask which states their prescribers are licensed in and you get a smaller number. Ask which states their pharmacy may ship into and you often get a shrug, because that one belongs to a partner.

The distance between those three answers is where most licensure findings live, and it is entirely discoverable from outside the business.

Three columns, not one

Build the matrix before anybody asks for it. Three columns, one row per state.

States you market in. Taken from your advertising targeting, your checkout's shipping rules and your intake's state selector, not from your intentions. This is the column businesses get wrong, because national targeting was switched on during launch week and never revisited.

States your prescribers are licensed in. By practitioner, with expiry dates. An individual roster rather than a summary, because a summary hides the prescriber whose licence lapsed in one state.

States your pharmacy may ship into. Non-resident licensure, from the pharmacy, in writing. A fulfilment platform's marketing map is not this.

Any row where the first column has an entry and either of the other two does not is a finding waiting to be made. Almost every clinic that builds this matrix for the first time finds at least one.

Why the gap is visible from outside

None of this requires your cooperation to check. Licence lookups are public, pharmacy registrations are public, and your advertising targeting is visible to anybody who sees an ad. A reviewer comparing what your site offers with what your roster supports is doing two searches, not an investigation.

Which is why the strategy of hoping a thin state goes unnoticed is worse than useless: it converts a fixable coverage problem into a credibility problem across the file, which is the pattern what disqualifies an application keeps returning to.

The fix is usually to narrow, not to widen

Operators instinctively reach for more licensure. Licensing takes months and costs money per practitioner per state, so it is the slow fix.

Narrowing the marketing is the fast one. Turn off the states you cannot serve properly, put a state selector at the top of the intake rather than at the bottom of the checkout, and say plainly which states you operate in. That is a change you can make this week, it costs nothing, and it removes the gap in both directions: the reviewer sees a coherent model, and patients stop reaching a decline at the payment screen.

Widen later, deliberately, when the licensure is actually in place.

The parts operators forget

Where the patient is, not where they registered. Licensure attaches to the patient's location at the time of the encounter. A model that never asks is a model that cannot answer the question.

Prescriber licences expire on their own schedule. A roster with no expiry dates is a roster that will develop a gap silently. Diarise renewals centrally rather than leaving them with the individual.

Contracted clinicians are still your coverage. Where prescribers come through a professional entity or a credentialing partner, the coverage question is unchanged and the evidence is one step further away. Ask for the roster and keep a copy.

Non-resident pharmacy licensure is per state and per pharmacy. A second pharmacy partner brings a second map, and it is rarely the same map.

Some states have their own telehealth registration. Where an additional registration applies to remote practice, it belongs in the matrix as its own check rather than being folded into licensure.

What to do when you find a gap in a live business

Most clinics build this matrix while already trading, and find a state where patients have been served without full coverage. Panic is the wrong response and so is silence.

Work it in this order. Stop the acquisition first: switch the state off in targeting and in the intake selector the same day, because every additional patient makes the remediation larger. Then establish the size of it honestly: how many patients, over what period, and whether the gap was on the prescribing side, the dispensing side, or both.

Then decide about continuity of care for the patients already receiving treatment, with the medical director rather than with marketing, because abruptly abandoning a patient mid-course is its own problem. And record what you did and when, because the value of that record is that it turns a finding into a handled incident.

Finally, decide whether the gap is disclosable. A live application makes that question easy: it is. A closed one makes it a judgement about materiality, and the safer instinct is the one that assumes the fact is discoverable, because it is.

What this looks like in the application

Supplied up front, the matrix answers a cluster of questions at once and demonstrates something more useful than compliance: that the business knows its own shape. Requested during a review, it is a round trip that depends on your pharmacy partner's response time as well as yours, which is exactly the kind of delay the rework loop is made of.

Keep it with the rest of the file, dated, with an owner, and re-read it whenever a prescriber joins or leaves, a pharmacy partner changes, or somebody switches on a new state in the ad account.

The one that catches multi-state brands

Expansion is usually a marketing decision. A growth lead adds five states to targeting because the cost per acquisition looks good there, and nobody in that conversation is holding the licence roster.

The cheapest structural fix is to make the matrix the gate: a state is not marketable until all three columns agree. Put it somewhere the growth team can see, make one person responsible for updating it, and treat switching on a state as a change that needs the same approval as a new product page.

Businesses that do this expand more slowly on paper and considerably faster in practice, because they stop having to unwind campaigns that were serving patients they could never have treated.

Frequently asked questions

Do my prescribers need to be licensed where the patient is?

Yes. Clinical practice in the United States is licensed state by state, and the state that matters is where the patient is at the time of the encounter rather than where they signed up or where the company is registered.

My pharmacy partner will not give me its state list. What now?

Treat that as a finding rather than an inconvenience. A reviewer will want the dispensing entity, its registration and its non-resident licensure, and a partner who cannot produce that list leaves a gap in your application you cannot close from your side.

Is it better to add licences or reduce the states I advertise in?

Narrowing the marketing is the fast fix and it costs nothing, so it is usually the right first move. Licensure takes months per practitioner per state, so widen deliberately once the coverage is genuinely in place.

General compliance information, not legal or medical advice.